5Grootheest ACV,Puijenbroek EPV,Jong LTD.Contribution of pharma- cists to the reporting of adverse drug reactions [J]. Pharmacoepidemiolo- gy and Drug Safety,2002,11:205-210.
6Shord SS, Fancctte SR,Gillenwater HH,et al. Gemcitabine pharmacoki- netics and interaction with paclitaxel in patients with advanced non- small-cell lung cancer [J]. Cancer Chemother Pharmaco1,2003,51:328.
7Grolleau F,Gamelin L, Boisdron" Celle M ,et al. A possibleexplanation for a neurotoxic effect of the anticancer agentoxaliplatin on neuronal voltage-gated sodium channels [J]. J Neurophsiol, 2001,85 (50) : 2293.
